ClinicalTrials.gg
RecruitingNCT07855393Updated Nov 12, 2026

Surface Topography and Radiographic Spinal Damage in Radiographic Axial Spondyloarthritis

An observational study in Axial Spondyloarthritis, Ankylosing Spondylitis and Spondylarthritis, sponsored by Ankara Etlik City Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Primary conditionSpondylitis, AnkylosingRegistry: Axial SpondyloarthritisReclassifiedWhy we changed it
Registry
Axial Spondyloarthritis — the first condition term the registry derived for this study.
ClinicalTrials.gg
Spondylitis, Ankylosing
Why
  1. The study's listed conditions name Spondylitis, Ankylosing, a narrower term within Axial Spondyloarthritis.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Ankara Etlik City Hospital · Observational

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Nov 12, 2026Study completion movedEligibility revised+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
53
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 84 studies in Spondylitis, Ankylosing with a site in Turkey — 19 open to participants now, 21 under way, none of them phase 3. Spondylitis, Ankylosing · Turkey.

Planned enrollment
29th of 35
53 · median 100
Started
2026
with 8 others
Observational
35 of 84
7 open now
Primary completion
2027-06
later than 17 of 20 live
Registered
81st of 84
by date

Among the 84 studies in Spondylitis, Ankylosing with a site in Turkey, this one is the 29th largest by planned enrollment of the 35 observational ones that give a count, is one of 9 that started in 2026, is one of 35 observational ones, reaches primary completion later than 17 of the 20 other live ones, and was the 81st registered.

Spondylitis, Ankylosing

535 studies on the registry are indexed under Spondylitis, Ankylosing; 100 are open to participants now.

Browse Spondylitis, Ankylosing studies →

Open to participants now

19 of the 84 studies in Spondylitis, Ankylosing with a site in Turkey are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 63 Spondylitis, Ankylosing studies recruiting now, 24 (38%) set no upper age limit and 33 (52%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 84 studies in Spondylitis, Ankylosing with a site in Turkey, or all of them as a file.
02

Study summary

Radiographic axial spondyloarthritis (r-axSpA) causes progressive structural damage of the spine, conventionally quantified on lateral cervical and lumbar radiographs using the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS). Repeated radiography entails cumulative radiation exposure, substantial inter-reader variability and low sensitivity in early disease. DIERS Formetric 4D (four-dimensional) surface topography (DIERS International GmbH, Schlangenbad, Germany) provides radiation-free three-dimensional modelling of the spine and pelvis. The association between sagittal balance and structural damage has been demonstrated with a radiation-based biplanar low-dose radiography system (EOS imaging, Paris, France), but whether a radiation-free topographic method reflects the same association has not been investigated.

This single-centre, cross-sectional observational study will enrol 53 adults with r-axSpA fulfilling the Assessment of SpondyloArthritis international Society (ASAS) criteria with radiographic sacroiliitis according to the modified New York criteria. At a single study visit, static DIERS Formetric 4D measurements, chest expansion, the Bath Ankylosing Spondylitis Metrology Index (BASMI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) are obtained. mSASSS is scored by a single reader, blinded to clinical and topographic data, on existing lateral cervical and lumbar radiographs obtained within the preceding 12 months; no additional radiographs are performed for the study. The primary analysis is the correlation between total mSASSS and the DIERS flèche cervicale (cervical sagittal anterior displacement).

Read the detailed description

Design: single-centre, cross-sectional, non-interventional correlation study in a single patient group; no control group. All participant data are collected in one assessment session lasting approximately 45 to 60 minutes.

Measurements: (a) demographic and anthropometric data; (b) disease duration, age at symptom onset, comorbidities, extra-articular involvement (uveitis, inflammatory bowel disease, psoriasis), human leukocyte antigen B27 (HLA-B27) status, current medication category; (c) radiographic sacroiliitis grade according to the modified New York criteria and the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS; range 0 to 72), scored by a single reader blinded to clinical and topographic data; (d) chest expansion; (e) the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP), the latter using routine C-reactive protein values with no additional blood sampling; (f) Bath Ankylosing Spondylitis Metrology Index (BASMI) total score and its five components; (g) DIERS Formetric 4D (four-dimensional) static parameters: flèche cervicale (cervical sagittal anterior displacement, mm), sagittal imbalance (mm and degrees), coronal imbalance (mm), pelvic obliquity (mm), pelvic torsion (degrees), cervical and lumbar depth distance (mm), kyphotic angle (degrees) and lordotic angle (degrees).

Statistical analysis: distribution is assessed with the Shapiro-Wilk test. The primary analysis is a Pearson or Spearman correlation between total mSASSS and flèche cervicale, reported with effect size and 95% confidence interval, followed by multiple linear regression adjusted for age and disease duration. Secondary analyses comprise correlations of DIERS parameters with clinical indices and an exploratory receiver operating characteristic analysis of the ability of DIERS sagittal parameters to predict mSASSS thresholds. The Benjamini-Hochberg procedure is applied to correct for multiple comparisons. Significance is set at p\<0.05. Analyses are performed with IBM SPSS Statistics (Statistical Package for the Social Sciences) version 23 or later.

Sample size: calculated with G*Power 3.1.9 for a bivariate normal correlation model, two-tailed, correlation under the null hypothesis (rho H0) = 0, expected effect size r = 0.40, alpha = 0.05 and power = 0.85, giving a required sample of 53 participants (actual power 0.857). The effect size was set conservatively at r = 0.40 rather than the r = 0.61 reported by Wanders et al. (2005) for occiput-to-wall distance versus mSASSS, because DIERS parameters are not identical to clinical mobility measures.

Reporting follows the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement.

03

Conditions studied

  • Axial Spondyloarthritis
  • Ankylosing Spondylitis
  • Spondylarthritis

Browse trials for

Keywords

  • surface topography
  • rasterstereography
  • DIERS Formetric
  • mSASSS
  • sagittal balance
  • spinal posture
  • radiation-free imaging
  • spinal mobility
  • modified Stoke Ankylosing Spondylitis Spine Score
04

In context

Spondylitis, Ankylosing Reclassified

535 studies on the registry are indexed under Spondylitis, Ankylosing; 100 are open to participants now.

This study's planned enrollment of 53 is below the median of 201 across 216 observational studies indexed under Spondylitis, Ankylosing.

Browse Spondylitis, Ankylosing studies →

Lead sponsor

Ankara Etlik City Hospital is the lead sponsor of 180 studies on the registry; 77 are open to participants now.

Compared within Spondylitis, Ankylosing, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Axial Spondyloarthritis. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

The criteria were revised on the registry on Nov 12, 2026. See what changed

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Consecutive patients with radiographic axial spondyloarthritis attending the spondyloarthritis outpatient clinic of the Department of Physical Medicine and Rehabilitation, Ankara Etlik City Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 to 65 years
  • Diagnosis of radiographic axial spondyloarthritis fulfilling the Assessment of SpondyloArthritis international Society (ASAS) criteria, confirmed by radiographic sacroiliitis according to the modified New York criteria
  • Able to provide written and to complete the assessments
  • Available lateral cervical and lumbar radiographs obtained within the 12 months preceding the DIERS measurement

Exclusion criteria

Exclusion Criteria:

  • Neurological disease affecting balance, posture or gait (for example Parkinson disease, amyotrophic lateral sclerosis, cerebellar or vestibular disorders, history of stroke)
  • History of lower extremity joint arthroplasty (hip or knee)
  • Orthopaedic conditions affecting posture, balance or gait (ununited fracture, previous spinal or lower extremity surgery)
  • Advanced cardiopulmonary disease, active infection or
  • Pregnancy
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

06

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
53 participants (estimated)
Patient registry
No

Groups and cohorts

  • Radiographic axial spondyloarthritis patients

    Adults aged 18 to 65 years with radiographic axial spondyloarthritis fulfilling the Assessment of SpondyloArthritis international Society (ASAS) classification criteria with radiographic sacroiliitis according to the modified New York criteria, attending the spondyloarthritis outpatient clinic. All participants undergo a single assessment session including static DIERS Formetric 4D surface topography, chest expansion and clinical indices: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI) and Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP). The modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) is scored on existing lateral cervical and lumbar radiographs obtained within the preceding 12 months; no additional radiographs are taken.

    Diagnostic Test: DIERS Formetric 4D surface topography

Interventions

  • Diagnostic testDIERS Formetric 4D surface topography

    Radiation-free three-dimensional assessment of spinal and pelvic surface topography performed once in standing position. No radiation, no contact, no intervention on treatment.

07

What researchers measure

Primary outcomes

  1. Correlation between total mSASSS and DIERS fleche cervicale

    Total modified Stoke Ankylosing Spondylitis Spine Score (mSASSS; range 0 to 72, higher scores indicate greater structural damage), correlated with flèche cervicale (cervical sagittal anterior displacement, mm) measured by DIERS Formetric 4D surface topography. Reported as a correlation coefficient with magnitude, direction and 95% confidence interval.

    Time frame: Single assessment session (Day 1); mSASSS scored on radiographs obtained within the 12 months preceding the assessment

Secondary outcomes

  1. Correlation between total mSASSS and other DIERS Formetric static parameters

    Total modified Stoke Ankylosing Spondylitis Spine Score (mSASSS; range 0 to 72, higher scores indicate greater structural damage) correlated with the remaining DIERS Formetric 4D static parameters: sagittal imbalance (mm and degrees), coronal imbalance (mm), pelvic obliquity (mm), pelvic torsion (degrees), cervical depth distance (mm), lumbar depth distance (mm), kyphotic angle (degrees) and lordotic angle (degrees). Reported as correlation coefficients with 95% confidence intervals.

    Time frame: Single assessment session (Day 1); mSASSS scored on radiographs obtained within the 12 months preceding the assessment

  2. Correlation between DIERS sagittal parameters and BASDAI

    Bath Ankylosing Spondylitis Disease Activity Index (range 0 to 10, higher scores indicate greater disease activity) correlated with DIERS Formetric 4D static parameters: flèche cervicale (mm), sagittal imbalance (mm and degrees), coronal imbalance (mm), pelvic obliquity (mm), pelvic torsion (degrees), cervical and lumbar depth distance (mm), kyphotic angle (degrees) and lordotic angle (degrees).

    Time frame: Single assessment session (Day 1)

  3. Correlation between DIERS sagittal parameters and BASFI

    Bath Ankylosing Spondylitis Functional Index (range 0 to 10, higher scores indicate worse physical function) correlated with DIERS Formetric 4D static parameters: flèche cervicale (mm), sagittal imbalance (mm and degrees), coronal imbalance (mm), pelvic obliquity (mm), pelvic torsion (degrees), cervical and lumbar depth distance (mm), kyphotic angle (degrees) and lordotic angle (degrees).

    Time frame: Single assessment session (Day 1)

  4. Correlation between DIERS sagittal parameters and BASMI

    Bath Ankylosing Spondylitis Metrology Index (range 0 to 10, higher scores indicate worse spinal mobility) correlated with DIERS Formetric 4D static parameters: fleche cervicale (mm), sagittal imbalance (mm and degrees), coronal imbalance (mm), pelvic obliquity (mm), pelvic torsion (degrees), cervical and lumbar depth distance (mm), kyphotic angle (degrees) and lordotic angle (degrees).

    Time frame: Single assessment session (Day 1)

  5. Correlation between DIERS sagittal parameters and ASDAS-CRP

    Ankylosing Spondylitis Disease Activity Score with C-reactive protein (higher scores indicate greater disease activity) correlated with DIERS Formetric 4D static parameters: fleche cervicale (mm), sagittal imbalance (mm and degrees), coronal imbalance (mm), pelvic obliquity (mm), pelvic torsion (degrees), cervical and lumbar depth distance (mm), kyphotic angle (degrees) and lordotic angle (degrees).

    Time frame: Single assessment session (Day 1)

  6. Correlation between DIERS sagittal parameters and chest expansion

    Chest expansion measured in centimetres correlated with DIERS Formetric 4D static parameters: flèche cervicale (mm), sagittal imbalance (mm and degrees), coronal imbalance (mm), pelvic obliquity (mm), pelvic torsion (degrees), cervical and lumbar depth distance (mm), kyphotic angle (degrees) and lordotic angle (degrees).

    Time frame: Single assessment session (Day 1)

  7. Discriminative performance of DIERS sagittal parameters for mSASSS thresholds

    Exploratory receiver operating characteristic analysis of DIERS Formetric 4D sagittal parameters for discriminating total modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) thresholds. Reported as area under the curve with 95% confidence interval, sensitivity and specificity.

    Time frame: Single assessment session (Day 1); mSASSS scored on radiographs obtained within the 12 months preceding the assessment

08

Study locations

1 of 1 sites recruiting
09

References and documents

Publications

  • Oliveira TL, Silva FD, Filho AGO, Nico MAC, Fernandes ARC, Ramiro S, Pinheiro MM. Relationship between spinal structural damage and sagittal balance in axial spondyloarthritis: Is the thoracic spine the starting point? Semin Arthritis Rheum. 2024 Apr;65:152415. doi: 10.1016/j.semarthrit.2024.152415. Epub 2024 Feb 7. PubMed 38340611 ↗
  • Wanders A, Landewe R, Dougados M, Mielants H, van der Linden S, van der Heijde D. Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation? Ann Rheum Dis. 2005 Jul;64(7):988-94. doi: 10.1136/ard.2004.029728. PubMed 15958757 ↗
  • Turk E, Yurdakul FG, Guler T, Bodur H. Posture, balance and gait in axial spondyloarthritis: a case-control study. Rheumatol Int. 2024 Nov;44(11):2527-2538. doi: 10.1007/s00296-024-05710-5. Epub 2024 Sep 4. PubMed 39230687 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared. According to the study protocol, research data are accessible only to the investigators. Aggregate results will be published.

10

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Sep 2026 (actual). Primary completion is estimated for Jun 2027, 9 months after the start.

Completion moved once since we started tracking on Sep 25, 2026: Aug 2027 → Jun 2027, on Nov 12, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 28, 2026
First posted
Oct 2, 2026
StartActual
Sep 19, 2026
Primary completionEst.
Jun 20, 2027
CompletionEst.
Jun 20, 2027was Aug 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Study completion
Aug 20, 2027→Jun 20, 2027
Nov 12, 2026
Eligibility
1 inclusion criterion edited
What changed in the criteria
Inclusion criteria
  • EditedDiagnosis of radiographic axial spondyloarthritis fulfilling the Assessment of SpondyloArthritis international Society (ASAS) criteria, confirmed by radiographic sacroiliitis according to the modified New York criteria
Nov 12, 2026
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionCorrelation between total mSASSS and DIERS fleche cervicale: how it is measured was reworded
Nov 12, 2026
Secondary outcomes
5 description edited
What changed in the outcomes
  • DescriptionCorrelation between DIERS sagittal parameters and BASDAI: how it is measured was reworded
  • DescriptionCorrelation between DIERS sagittal parameters and BASFI: how it is measured was reworded
  • DescriptionCorrelation between DIERS sagittal parameters and chest expansion: how it is measured was reworded
  • DescriptionCorrelation between total mSASSS and other DIERS Formetric static parameters: how it is measured was reworded
  • DescriptionDiscriminative performance of DIERS sagittal parameters for mSASSS thresholds: how it is measured was reworded
Nov 12, 2026
Registered
First appeared on the registry
Oct 2, 2026
Show all 2 updates
  1. Nov 12, 2026
    Study completion Aug 20, 2027→Jun 20, 2027
    Eligibility 1 inclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • EditedDiagnosis of radiographic axial spondyloarthritis fulfilling the Assessment of SpondyloArthritis international Society (ASAS) criteria, confirmed by radiographic sacroiliitis according to the modified New York criteria
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionCorrelation between total mSASSS and DIERS fleche cervicale: how it is measured was reworded
    Secondary outcomes 5 description edited
    What changed in the outcomes
    • DescriptionCorrelation between DIERS sagittal parameters and BASDAI: how it is measured was reworded
    • DescriptionCorrelation between DIERS sagittal parameters and BASFI: how it is measured was reworded
    • DescriptionCorrelation between DIERS sagittal parameters and chest expansion: how it is measured was reworded
    • DescriptionCorrelation between total mSASSS and other DIERS Formetric static parameters: how it is measured was reworded
    • DescriptionDiscriminative performance of DIERS sagittal parameters for mSASSS thresholds: how it is measured was reworded
    + 7 other changes: identifiers, verification date, description, conditions, design details, arm descriptions and data sharing statement
  2. Oct 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07855393
Responsible party
Seyma Alkan (Specialist Physician, Department of Physical Medicine and Rehabilitation, Ankara Etlik City Hospital, Ankara Etlik City Hospital) — Principal investigator
First posted
Oct 2, 2026
Start date
Sep 19, 2026
Primary completion
Jun 20, 2027 (estimated)
Completion
Jun 20, 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

Seyma Alkan, MD
Contact
symalkan@gmail.com
+90 538 337 97 91
Yasemin Tombak Yildizkan, MD
Contact
yasemintombak@hotmail.com
+90 505 402 97 63
Ajda Bal
principal investigator · Professor of Physical Medicine and Rehabilitation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion